Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
8 studies found for:    15640920 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Quantification of Posterior Capsule Opacification in Cataract Pediatric.
Condition: Posterior Capsule Opacification
Interventions: Procedure: Cataract Surgery;   Device: Alcon AcrySof SA60AT;   Device: Bausch Lomb AkreosA
2 Not yet recruiting Dose Ranging Study of Carbidopa-levodopa
Condition: Age-related Macular Degeneration
Intervention: Drug: Carbidopa-Levodopa, 25 Mg-100 Mg Oral Tablet
3 Not yet recruiting Carbidopa-levodopa in Neovascular AMD
Condition: Age-related Macular Degeneration
Intervention: Drug: carbidopa-levodopa25-100 mg tablets
4 Not yet recruiting A Safety and Efficacy Study of Carbidopa-levodopa in Patients With Macular Degeneration
Condition: Age-related Macular Degeneration
Interventions: Drug: carbidopa-levodopa 25-100 mg;   Drug: placebo for carbidopa-levodopa 25-100 mg
5 Completed Macular Pigment Density Evolution in Unilateral Wet AMD Versus Non AMD Patients With or Without Lutein and Zeaxanthine Supplementation
Condition: Exudative Age-related Macular Degeneration
Interventions: Dietary Supplement: Nutrof Total;   Dietary Supplement: food supplement without Lutein and Zeaxanthin
6 Completed Lutein Influence on Macula of Persons Issued From Amd Parents
Condition: Persons Issued From Amd Parents
Interventions: Dietary Supplement: Nutrof Total;   Dietary Supplement: Placebo Nutrof total
7 Completed Economic Evaluation of Femtosecond Laser Assisted Cataract Surgery
Condition: Cataract
Interventions: Procedure: Cataract surgery with Phacoemulsification;   Device: Femtosecond laser-assisted cataract surgery
8 Unknown  Efficacy of Ranibizumab in Combination With Photodynamic Therapy for Wet Age-Related Macular Degeneration
Conditions: Macular Degeneration;   Visual Acuity
Intervention: Drug: Ranibizumab

Study has passed its completion date and status has not been verified in more than two years.